About Us
Orot-Luces is dedicated to taking part in the future of cancer care. Our mission is to invest in and support the development of new medical technologies and innovations that have the potential to improve the lives of people everywhere.
Our Focus Is Cancer Care Innovation
We focus on investing in early-stage, early-commercial healthcare companies with innovative solutions, putting our resources into medical companies, products, and services that promise to revolutionize medical care. We believe in fostering breakthrough medical technologies and supporting companies that are working to improve patient outcomes.
The VC-PE Hybrid Model
At Orot Luces, we operate in the space between Venture Capital and Private Equity – creating a different perspective on standard investment paradigms. Our methodology is centered around our direct and in-person connections with our portfolio companies and our vast strategic partners.
We don’t just invest – we participate, providing actionable solutions to the companies' needs and problems. Our ‘boots on the ground’ mindset delivers growth and opens new markets and opportunities.
Our Platform
Based on our direct acquaintance and access to global networks, combined with hands-on professional management. We are combining intimate medical knowledge with a robust understanding of the investment world.
Our Vast Experience
Having a proven track record for over 4 decades of execution in the healthcare field with established, operated, and profitable businesses worth hundreds of millions of euros, our team’s focused approach has delivered favorable risk-adjusted returns across different healthcare services and biotech companies.
At The Center of The Hub
At the heart of Israel’s life science hub, we are part of a dynamic business culture. It’s an excellent window of opportunity for investing with us due to the very few investors and VC players, the significant unmet needs, and the number of people living with cancer is constantly growing.
Team of Experts
Our team brings a proven track record of over four decades in the healthcare field, successfully growing and selling multinational healthcare businesses and biotech ventures.